ArticleScientific reports2019

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

Toshihiro Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.